{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:19:31Z","timestamp":1786987171976,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.compbiomed.2024.108991","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T08:35:47Z","timestamp":1723192547000},"page":"108991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Unveiling structural determinants for FXR antagonism in 1,3,4-trisubstituted-Pyrazol amide derivatives: A multi-scale in silico modelling approach"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0664-0389","authenticated-orcid":false,"given":"Soumya","family":"Mitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4818-9047","authenticated-orcid":false,"given":"Amit Kumar","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6866-9768","authenticated-orcid":false,"given":"Arup","family":"Koley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanjan","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0071-708X","authenticated-orcid":false,"given":"Parthasarathi","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash C.","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3375-8670","authenticated-orcid":false,"given":"Maria Natalia D.S.","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.compbiomed.2024.108991_bib1","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108991_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.compbiomed.2024.108991_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/nu15030687","article-title":"Understanding NAFLD: from case identification to interventions, outcomes, and future perspectives","volume":"15","author":"Clayton-Chubb","year":"2023","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.compbiomed.2024.108991_bib4","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.compbiomed.2024.108991_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2022.02.006","article-title":"Nafld\/nash","volume":"77","author":"Bugianesi","year":"2022","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.compbiomed.2024.108991_bib6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2010.04.031","article-title":"Hepatocellular ballooning in NASH","volume":"53","author":"Caldwell","year":"2010","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.compbiomed.2024.108991_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cld.2015.10.011","article-title":"Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children","volume":"20","author":"Kleiner","year":"2016","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.compbiomed.2024.108991_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin. Med."},{"issue":"3","key":"10.1016\/j.compbiomed.2024.108991_bib9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Shalimar","year":"2022","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108991_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jceh.2015.02.006","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome-position paper of the Indian national association for the study of the liver, endocrine society of India, Indian college of cardiology and Indian society of gastroenterology","volume":"5","author":"Duseja","year":"2015","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.compbiomed.2024.108991_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.clnu.2013.11.003","article-title":"Diets and nonalcoholic fatty liver disease: the good and the bad","volume":"33","author":"Asrih","year":"2014","journal-title":"Clin. Nutr. (Edinb.)"},{"issue":"3","key":"10.1016\/j.compbiomed.2024.108991_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jada.2011.10.007","article-title":"The role of diet and nutrient composition in nonalcoholic Fatty liver disease","volume":"112","author":"McCarthy","year":"2012","journal-title":"J. Acad. Nutr. Diet."},{"issue":"4","key":"10.1016\/j.compbiomed.2024.108991_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MCO.0000000000000762","article-title":"Beyond weight loss in nonalcoholic fatty liver disease: the role of carbohydrate restriction","volume":"24","author":"Risi","year":"2021","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"3","key":"10.1016\/j.compbiomed.2024.108991_bib14","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.compbiomed.2024.108991_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104262","article-title":"Design, synthesis and structure-activity relationship studies of novel partial FXR agonists for the treatment of fatty liver","volume":"104","author":"Qiu","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"21","key":"10.1016\/j.compbiomed.2024.108991_bib16","doi-asserted-by":"crossref","first-page":"12748","DOI":"10.1021\/acs.jmedchem.0c01065","article-title":"Discovery and optimization of non-bile acid FXR agonists as preclinical candidates for the treatment of nonalcoholic steatohepatitis","volume":"63","author":"Li","year":"2020","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.compbiomed.2024.108991_bib17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/13543784.2020.1763302","article-title":"Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)","volume":"29","author":"Fiorucci","year":"2020","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108991_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI0215387","article-title":"Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype","volume":"110","author":"Pullinger","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.compbiomed.2024.108991_bib19","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1194\/jlr.M300182-JLR200","article-title":"FXR-mediated down-regulation of CYP7A1 dominates LXRalpha in long-term cholesterol-fed NZW rabbits","volume":"44","author":"Xu","year":"2003","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.compbiomed.2024.108991_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbagrm.2011.01.008","article-title":"Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter","volume":"1809","author":"Renga","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.compbiomed.2024.108991_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hep.30810","article-title":"Direct and indirect effects of Fibroblast Growth factor (FGF) 15 and FGF19 on liver fibrosis development","volume":"71","author":"Schumacher","year":"2020","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.compbiomed.2024.108991_bib22","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1517\/13543776.2010.496777","article-title":"Farnesoid X receptor modulators: a patent review","volume":"20","author":"Crawley","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"issue":"8","key":"10.1016\/j.compbiomed.2024.108991_bib23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/13543776.2015.1045413","article-title":"Farnesoid X receptor modulators (2011 - 2014): a patent review","volume":"25","author":"Sepe","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"issue":"5","key":"10.1016\/j.compbiomed.2024.108991_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/13543776.2018.1459569","article-title":"Farnesoid X receptor modulators 2014-present: a patent review","volume":"28","author":"Sepe","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"19","key":"10.1016\/j.compbiomed.2024.108991_bib25","doi-asserted-by":"crossref","first-page":"13452","DOI":"10.1021\/acs.jmedchem.2c01394","article-title":"Discovery of betulinic acid derivatives as potent intestinal farnesoid X receptor antagonists to ameliorate nonalcoholic steatohepatitis","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.compbiomed.2024.108991_bib26","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.bmc.2014.04.014","article-title":"Identification of trisubstituted-pyrazol carboxamide analogs as novel and potent antagonists of farnesoid X receptor","volume":"22","author":"Yu","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.compbiomed.2024.108991_bib27","unstructured":"Advanced Chemistry Development, I.A.L. ACD\/ChemSketch, version 2021.1.2, Toronto, ON, Canada. Available from:: www.acdlabs.com."},{"key":"10.1016\/j.compbiomed.2024.108991_bib28","series-title":"ChemAxon Standardizer","year":"2010"},{"issue":"5","key":"10.1016\/j.compbiomed.2024.108991_bib29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1021\/ci010368v","article-title":"Prediction of n-octanol\/water partition coefficients from PHYSPROP database using artificial neural networks and E-state indices","volume":"41","author":"Tetko","year":"2001","journal-title":"J. Chem. Inf. Comput. Sci."},{"issue":"4","key":"10.1016\/j.compbiomed.2024.108991_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","article-title":"Beware of q2","volume":"20","author":"Golbraikh","year":"2002","journal-title":"J. Mol. Graph. Model."},{"issue":"5","key":"10.1016\/j.compbiomed.2024.108991_bib31","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3390\/molecules14051660","article-title":"On two novel parameters for validation of predictive QSAR models","volume":"14","author":"Pratim Roy","year":"2009","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.compbiomed.2024.108991_bib32","first-page":"9","article-title":"A study of effects of MultiCollinearity in the multivariable analysis","volume":"4","author":"Yoo","year":"2014","journal-title":"Int. J. Appl. Sci. Technol."},{"issue":"6","key":"10.1016\/j.compbiomed.2024.108991_bib33","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/ci700157b","article-title":"y-Randomization and its variants in QSPR\/QSAR","volume":"47","author":"Rucker","year":"2007","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.compbiomed.2024.108991_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.chemolab.2011.08.007","article-title":"Comparative QSARs for antimalarial endochins: importance of descriptor-thinning and noise reduction prior to feature selection","volume":"109","author":"P.K","year":"2011","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.compbiomed.2024.108991_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.chemolab.2015.04.013","article-title":"On a simple approach for determining applicability domain of QSAR models","volume":"145","author":"Roy","year":"2015","journal-title":"Chemometr. Intell. Lab. Syst."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108991_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13321-021-00537-9","article-title":"QPHAR: quantitative pharmacophore activity relationship: method and validation","volume":"13","author":"Kohlbacher","year":"2021","journal-title":"J. Cheminf."},{"key":"10.1016\/j.compbiomed.2024.108991_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106789","article-title":"Multi-model in silico characterization of 3-benzamidobenzoic acid derivatives as partial agonists of Farnesoid X receptor in the management of NAFLD","volume":"157","author":"Mitra","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"9","key":"10.1016\/j.compbiomed.2024.108991_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ph15091122","article-title":"Applications of the novel quantitative pharmacophore activity relationship method QPhAR in virtual screening and lead-optimisation","volume":"15","author":"Kohlbacher","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"8","key":"10.1016\/j.compbiomed.2024.108991_bib39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10822-011-9462-9","article-title":"Open3DALIGN: an open-source software aimed at unsupervised ligand alignment","volume":"25","author":"Tosco","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.compbiomed.2024.108991_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2023.108640","article-title":"Finding structural requirements of structurally diverse alpha-glucosidase and alpha-amylase inhibitors through validated and predictive 2D-QSAR and 3D-QSAR analyses","volume":"126","author":"Mitra","year":"2024","journal-title":"J. Mol. Graph. Model."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108991_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00894-010-0684-x","article-title":"Open3DQSAR: a new open-source software aimed at high-throughput chemometric analysis of molecular interaction fields","volume":"17","author":"Tosco","year":"2011","journal-title":"J. Mol. Model."},{"issue":"5","key":"10.1016\/j.compbiomed.2024.108991_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac201","article-title":"fastDRH: a webserver to predict and analyze protein-ligand complexes based on molecular docking and MM\/PB(GB)SA computation","volume":"23","author":"Wang","year":"2022","journal-title":"Briefings Bioinf."},{"issue":"32","key":"10.1016\/j.compbiomed.2024.108991_bib43","doi-asserted-by":"crossref","first-page":"19888","DOI":"10.1074\/jbc.M114.630475","article-title":"Structural basis for small molecule NDB (N-benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) benzamide) as a selective antagonist of farnesoid X receptor alpha (FXRalpha) in stabilizing the homodimerization of the receptor","volume":"290","author":"Xu","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.compbiomed.2024.108991_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/biom11111670","article-title":"Multi-Target in silico prediction of inhibitors for mitogen-activated protein kinase-interacting kinases","volume":"11","author":"Halder","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.compbiomed.2024.108991_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1004255","article-title":"In silico characterization of aryl benzoyl hydrazide derivatives as potential inhibitors of RdRp enzyme of H5N1 influenza virus","volume":"13","author":"Ghosh","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"Web Server issue","key":"10.1016\/j.compbiomed.2024.108991_bib46","doi-asserted-by":"crossref","first-page":"W522","DOI":"10.1093\/nar\/gkm276","article-title":"PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations","volume":"35","author":"Dolinsky","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.compbiomed.2024.108991_bib47","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theor. Comput."},{"issue":"8","key":"10.1016\/j.compbiomed.2024.108991_bib48","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jmgm.2008.12.006","article-title":"Comparison of computational approaches for predicting the effects of missense mutations on p53 function","volume":"27","author":"Chong","year":"2009","journal-title":"J. Mol. Graph. Model."},{"issue":"17","key":"10.1016\/j.compbiomed.2024.108991_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28176379","article-title":"In silico modeling and structural analysis of soluble epoxide hydrolase inhibitors for enhanced therapeutic design","volume":"28","author":"Sar","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.compbiomed.2024.108991_bib50","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/ci010132r","article-title":"Reoptimization of MDL keys for use in drug discovery","volume":"42","author":"Durant","year":"2002","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.compbiomed.2024.108991_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2164-6-35","article-title":"Silhouette scores for assessment of SNP genotype clusters","volume":"6","author":"Lovmar","year":"2005","journal-title":"BMC Genom."},{"key":"10.1016\/j.compbiomed.2024.108991_bib52","article-title":"Identification of key structural features of phosphate and thiophosphate tricyclic coumarin analogs as STS inhibitors","volume":"12","author":"Srimathi Radha","year":"2021","journal-title":"Med. Drug Discov"},{"issue":"2","key":"10.1016\/j.compbiomed.2024.108991_bib53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/157340912800492366","article-title":"Electrotopological state atom (E-state) index in drug design, QSAR, property prediction and toxicity assessment","volume":"8","author":"Roy","year":"2012","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.compbiomed.2024.108991_bib54","series-title":"Handbook of Molecular Descriptors","author":"Todeschini","year":"2008"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108991_bib55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-2946-1-8","article-title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","volume":"1","author":"Ertl","year":"2009","journal-title":"J. Cheminf."},{"issue":"11","key":"10.1016\/j.compbiomed.2024.108991_bib56","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.bmc.2019.04.029","article-title":"Identification of potent farnesoid X receptor (FXR) antagonist showing favorable PK profile and distribution toward target tissues: comprehensive understanding of structure-activity relationship of FXR antagonists","volume":"27","author":"Teno","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.compbiomed.2024.108991_bib57","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.csbj.2021.04.029","article-title":"Farnesoid X receptor (FXR): structures and ligands [published correction appears in comput struct biotechnol J. 2022 mar 01;20:1227-1228]","volume":"19","author":"Jiang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"4","key":"10.1016\/j.compbiomed.2024.108991_bib58","article-title":"When two become one: conformational changes in FXR\/RXR heterodimers bound to steroidal antagonists","volume":"18","author":"D\u00edaz-Holgu\u00edn","year":"2023","journal-title":"ChemMedChem"}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001048252401076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001048252401076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T17:15:17Z","timestamp":1727370917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001048252401076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":58,"alternative-id":["S001048252401076X"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108991","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling structural determinants for FXR antagonism in 1,3,4-trisubstituted-Pyrazol amide derivatives: A multi-scale in silico modelling approach","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108991"}}